Hearing on “Combating the Opioid Crisis: Prevention and Public Health Solutions,” Subcommittee on Health (March 21, 2018)

Livestream

Part I:

Part II:

Key Documents

Memorandum from Ranking Member Pallone to the Subcommittee on Health

Opening Statement of Ranking Member Pallone as prepared for delivery

Opening Statement of Subcommittee Ranking Member Green as prepared for delivery

Preliminary Transcript I

Preliminary Transcript II

Legislation

H.R. 449, Synthetic Drug Awareness Act, To require the Surgeon General of the Public Health Service to submit to Congress a report on the effects on public health of the increased rate of use of synthetic drugs. 

H.R. 5002, Advancing Cutting Edge Research Act, To expand the unique research initiatives authority of the National Institutes of Health. 

H.R. 5009, Jessie's Law, To include information concerning a patient’s opioid addiction in certain medical records.

H.R. 5102, Substance Use Disorder Workforce Loan Repayment Act, To amend the Public Health Service Act to authorize a loan repayment program for substance use disorder treatment employees, and for other purposes.

H.R. 5140, Tribal Addiction and Recovery Act, To make improvements to the Account For the State Response to the Opioid Abuse Crisis to improve tribal health. 

H.R. 5176, Preventing Overdoses While in Emergency Rooms Act, To require the Secretary of Health and Human Services to provide coordinated care to patients who have experienced a non-fatal overdose after emergency room discharge, and for other purposes. 

H.R. 5197, Alternatives to Opioids in the Emergency Department Act, To direct the Secretary of Health and Human Services to conduct a demonstration program to test alternative pain management protocols to limit the use of opioids in hospital-based emergency departments. 

H.R. 5261, Treatment, Education, and Community Help to Combat Addiction Act, To amend the Public Health Service Act to provide for regional centers of excellence in substance use disorder education, and for other purposes. 

H.R. 5272, Reinforcing Evidence-Based Standards Under Law in Treating Substance Abuse Act, To ensure that programs and activities that are funded by a grant, cooperative agreement, loan, or loan guarantee from the Department of Health and Human Services, and whose purpose is to prevent or treat a mental health or substance use disorder, are evidence-based. 

Discussion Draft of H.R. __, Poison Center Network Enhancement Act, To amend the Public Health Service Act to reauthorize and enhance the poison center national toll-free number, national media campaign, and grant program, and for other purposes. 

Discussion Draft of H.R. __, A Bill to Improve Fentanyl Testing and Surveillance, To authorize the Secretary of Health and Human Services to conduct programs to address the usage of illicit drugs, particularly fentanyl, and for other purposes.

Discussion Draft of H.R. __, Eliminating Opioid-Related Infectious Diseases Act, To amend the Public Health Service Act to reauthorize and expand a program of surveillance and education, carried out by the Centers for Disease Control and Prevention, regarding infections associated with injection drug use. 

Discussion Draft of H.R. __, Comprehensive Opioid Recovery Centers Act, To amend title V of the Public Health Service Act to establish a grant program to create comprehensive opioid recovery centers, and for other purposes. 

Discussion Draft of H.R. __, A Bill to Enhance and Improve State-run Prescription Drug Management Plans, To amend the Public Health Service Act to authorize the Director of the Centers for Disease Control and Prevention to carry out certain activities to prevent controlled substances overdoses, and for other purposes.

Discussion Draft of H.R. __, A Bill to Support the Peer Support Specialist Workforce, To amend the Public Health Service Act to authorize certain recovery services grants to be used to establish regional technical assistance centers. 

Discussion Draft of H.R. __, FDA Accelerated Approval and Breakthrough Therapy Status, To amend the Federal Food, Drug, and Cosmetic Act to require the Secretary of Health and Human Services to issue guidance with respect to the accelerated approval of certain drugs, and for other purposes.

Discussion Draft of H.R. __, FDA and International Mail, To amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of certain drugs, and for other purposes. 

Discussion Draft of H.R. __, FDA Opioid Sparing, To direct the Secretary of Health and Human Services to update or issue guidance addressing alternative methods for data collection on opioid sparing and inclusion of such data in product labeling, and for other purposes. 

Discussion Draft of H.R. __, FDA Packaging and Disposal, To amend the Federal Food, Drug, and Cosmetic Act to require improved packaging and disposal methods with respect to certain drugs, and for other purposes.

Discussion Draft of H.R. __, FDA Long-term Efficacy, To amend the Federal Food, Drug, and Cosmetic Act with respect to postapproval study requirements for certain controlled substances, and for other purposes.

Discussion Draft of H.R. __, FDA Misuse/Abuse, To amend the Federal Food, Drug, and Cosmetic Act to authorize the Secretary of Health and Human Services to consider the potential for misuse and abuse when determining whether to approve certain drugs, and for other purposes.

Witnesses